Therapy of amyloid diseases.
Deposition of amyloid in the organism can lead to severe clinical symptoms and syndromes which are referred to as amyloidosis. However, amyloidosis is not a pathogenetically single disease entity. Various amyloid diseases are known which can clearly be distinguished by identifying the protein from which the amyloid is derived. Since the amyloid syndromes are pathogenetically diverse, each of the different amyloid diseases needs to be treated differently, and a type-specific amyloid therapy is mandatory. Unfortunately, an efficient therapy is not yet available for most amyloid syndromes. It is the purpose of this review to show how the different amyloid syndromes are distinguished definitively from each other and what has been successful in the effort to establish an efficient therapy of the various amyloid deposits and different amyloidoses.
Linke
R P
RP
Max-Planck-Institute of Biochemistry, Munich, Germany.
D000686:Amyloidosis / Q000145:classification / Q000628:therapy*; D006801:Humans; D007674:Kidney Diseases / Q000628:therapy; D000685:Serum Amyloid A Protein
D000685:Serum Amyloid A Protein